160 related articles for article (PubMed ID: 10401183)
1. [Action of SERM and SAS (tibolone) on breast tissue].
Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P
Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183
[TBL] [Abstract][Full Text] [Related]
2. Searching for the ideal SERM.
Poletti A
Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989
[No Abstract] [Full Text] [Related]
3. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
4. [Effects and mechanism of action of antiestrogens in breast cancer].
Borgna JL; Rochefort H
Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
[TBL] [Abstract][Full Text] [Related]
5. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
6. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
Jovanović-Mićić D; Beleslin DB; Nikolić SS
Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
[TBL] [Abstract][Full Text] [Related]
7. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Johnston SR
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
[TBL] [Abstract][Full Text] [Related]
8. [Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action].
Maudelonde T; Brouillet JP; Pujol P
Contracept Fertil Sex; 1999 Sep; 27(9):620-4. PubMed ID: 10540506
[TBL] [Abstract][Full Text] [Related]
9. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
Robertson JF
Cancer Treat Rev; 2004 Dec; 30(8):695-706. PubMed ID: 15541579
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen, raloxifene and the prevention of breast cancer.
Bentrem DJ; Craig Jordan V
Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
[TBL] [Abstract][Full Text] [Related]
11. RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
Sgroi DC; Haber DA; Ryan PD; Ma XJ; Erlander MG
Cancer Cell; 2004 Nov; 6(5):445. PubMed ID: 15542428
[No Abstract] [Full Text] [Related]
12. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
13. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
14. Targeted antiestrogens.
Tonetti DA; Jordan VC
Prog Clin Biol Res; 1997; 396():245-55. PubMed ID: 9108602
[No Abstract] [Full Text] [Related]
15. [Anti-hormonal therapy in breast cancer].
Ecker-Schlipf B
Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
[No Abstract] [Full Text] [Related]
16. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
Trunet P; Marty M
Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
18. In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.
Fichtner I; Becker M; Zeisig R; Sommer A
Eur J Cancer; 2004 Apr; 40(6):845-51. PubMed ID: 15120040
[TBL] [Abstract][Full Text] [Related]
19. [Antiestrogens: mechanism of action and clinical applications].
Barrón-González A; Arias-Martínez J; Castro-Romero I
Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]